
Payman Zamani MD
Heart Failure & Transplantation, Interventional Cardiology, Exercise Physiology and Cardiac Rehabilitation
Physician
Join to View Full Profile
3400 Spruce StPhiladelphia, PA 19104
Phone+1 215-662-4949
Fax+1 215-673-0718
Dr. Zamani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Payman Zamani, MD, is a Cardiology specialist based in Philadelphia, PA, with subspecialties in Heart Failure & Transplantation, Interventional Cardiology, Exercise Physiology, and Cardiac Rehabilitation. He completed his residency in Internal Medicine at Brigham and Women's Hospital and his fellowship in Advanced Heart Failure and Transplant Cardiology at the University of California (San Diego) Medical Center. Dr. Zamani is experienced in heart failure and exercise stress testing. He has multiple publications in reputed journals, including the Journal of the American Heart Association and Circulation: Heart Failure. Dr. Zamani has also been involved in clinical trials focusing on heart failure with preserved ejection fraction (HFpEF).
Education & Training
- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2007 - 2010
- Harvard Medical SchoolClass of 2007
- University of California (San Diego) Medical CenterFellowship, Advanced Heart Failure and Transplant Cardiology
Certifications & Licensure
- CA State Medical License 2010 - 2027
- PA State Medical License 2011 - 2026
- MA State Medical License 2009 - 2010
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Effect of KNO3 Compared to KCl on Oxygen UpTake in Heart Failure With Preserved Ejection Fraction (KNO3CK OUT HFPEF) Start of enrollment: 2016 Aug 01
- Matching Perfusion and Metabolic Activity in HFpEF Start of enrollment: 2021 Oct 11
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Musclin Counteracts Skeletal Muscle Dysfunction and Exercise Intolerance in Heart Failure With Preserved Ejection Fraction.Eng Leng Saw, Louis Dominic Werner, Hannah L Cooper, David R Pimental, Payman Zamani
Circulation. Heart Failure. 2025-05-13 - Crossover Trial of Exogenous Ketones on Cardiometabolic Endpoints in Heart Failure With Preserved Ejection Fraction.Senthil Selvaraj, Antoneta Karaj, Julio A Chirinos, Nicole Denney, Gabby Grosso
JACC. Heart Failure. 2025-03-29 - 1 citationsPotassium Nitrate in Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.Payman Zamani, Sanjiv J Shah, Jordana B Cohen, Manyun Zhao, Wei Yang
JAMA Cardiology. 2025-03-01
Press Mentions
- Potassium Nitrate Fails to Boost Exercise Capacity in Patients with Heart Failure with Preserved Ejection FractionDecember 24th, 2024
Grant Support
- Multidrug Metabolic Approach to Improve Exercise and Skeletal Muscle Oxidative Capacity in HFpEFUNIVERSITY OF PENNSYLVANIA2021–2026
- Targeting Skeletal Muscle Perfusion and Oxidative Capacity in HFpEFUNIVERSITY OF PENNSYLVANIA2021–2026
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: